PTEN C124R [cytosol]

Stable Identifier
R-HSA-2317439
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Synonyms
PTEN Cys124Arg
PTEN C124R [cytosol] icon
Locations in the PathwayBrowser
General
PTEN missense mutation that results in the substitution of cysteine at position 124 with arginine affects the conserved H-C-K/R-A-G-K-G-R sequence (corresponding to HCXXGXXR motif of protein tyrosine phosphatases) in the catalytic cleft of the PTEN phosphatase domain. The cystein residue in this motif, corresponding to C124 of human PTEN, 'attacks' the phosphate group of a substrate and forms a thio-phosphate intermediate during dephosphorylation reaction (Guan and Dixon 1991, Barford et al. 1994, Lee et al. 1999). PTEN C124R (Cys124Arg) mutant shows markedly decreased phosphoinositide phosphatase activity (Han et al. 2000). PTEN C124R is found as a germline mutation in Cowden syndrome, an autosomal dominant cancer syndrome (Nelen et al. 1997).
Literature References
PubMed ID Title Journal Year
1654322 Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate

Guan, KL, Dixon, JE

J. Biol. Chem. 1991
8128219 Crystal structure of human protein tyrosine phosphatase 1B

Barford, D, Flint, AJ, Tonks, NK

Science 1994
9259288 Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease

Lindboe, CF, Mariman, EC, Hassel, MB, Fryns, JP, Peeters, EA, Gorlin, RJ, Hamm, H, Nelen, MR, Kremer, H, Sijmons, RH, Padberg, GW, van Staveren, WC, Woods, DG

Hum. Mol. Genet. 1997
10866302 Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay

Kato, H, Shibata, H, Matsuno, S, Shiiba, K, Han, SY, Kato, S, Ishioka, C, Ishii, S, Kanamaru, R, Suzuki, T

Cancer Res 2000
10555148 Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association

Georgescu, MM, Pavletich, NP, Shi, Y, Maehama, T, Pandolfi, P, Yang, H, Lee, JO, Dixon, JE, Di Cristofano, A

Cell 1999
Participates
Other forms of this molecule
Modified Residues
Name
L-cysteine 124 replaced with L-arginine
Coordinate
124
PsiMod
A protein modification that effectively removes or replaces an L-cysteine.
A protein modification that effectively converts a source amino acid residue to an L-arginine.
Disease
Name Identifier Synonyms
Cowden syndrome DOID:6457 multiple hamartoma syndrome
thyroid adenoma DOID:2891 Thyroid adenoma (disorder), adenoma of thyroid gland, adenoma of the Thyroid gland, adenoma thyroid gland, adenoma thyroid gland
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Interactors (26)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:O14745 NHRF1      0.771 7
 UniProt:P09619 PDGFRB  3 0.675 3
 UniProt:Q15599 NHRF2      0.639 5
 UniProt:P42685 FRK  4 0.639 7
 UniProt:Q5TCQ9 MAGI3      0.633 6
 UniProt:Q06830 PRDX1  3 0.632 7
 UniProt:P30260 CDC27  2 0.616 7
 UniProt:P60484 PTEN  20 0.615 9
 UniProt:O43791 SPOP  1 0.611 4
 UniProt:P35226 BMI1  3 0.61 7
 UniProt:Q9R1L5 MAST1      0.593 3
 UniProt:O60307 MAST3      0.593 3
 UniProt:Q60592 MAST2      0.593 4
 UniProt:P46934 NEDD4  1 0.591 4
 UniProt:O88382 MAGI2      0.581 3
 UniProt:Q9JHL1 NHRF2      0.524 2
 UniProt:P62136 PPP1CA  1 0.524 2
 UniProt:Q9NRD5 PICK1  2 0.508 2
 UniProt:Q9JK71 MAGI3      0.508 3
 UniProt:Q9P0U4 CXXC1  1 0.508 2
 UniProt:Q03135 CAV1  5 0.499 2
 UniProt:Q9ULX6 AKAP8L  1 0.499 2
 UniProt:Q16643 DBN1  1 0.471 5
 UniProt:Q9UJX3 ANAPC7  2 0.462 2
 UniProt:Q9UJX5 ANAPC4  2 0.462 2
 UniProt:Q9UJX4 ANAPC5  2 0.462 2
Cite Us!